Transcriptomic response of peripheral blood mononuclear cells to secukinumab in epidermolytic ichthyosis

Clin Exp Dermatol. 2024 May 21;49(6):626-628. doi: 10.1093/ced/llae040.
No abstract available

Publication types

  • Letter

MeSH terms

  • Adult
  • Antibodies, Monoclonal, Humanized* / therapeutic use
  • Female
  • Humans
  • Hyperkeratosis, Epidermolytic* / drug therapy
  • Hyperkeratosis, Epidermolytic* / genetics
  • Hyperkeratosis, Epidermolytic* / pathology
  • Leukocytes, Mononuclear* / drug effects
  • Leukocytes, Mononuclear* / metabolism
  • Male
  • Transcriptome

Substances

  • secukinumab